Gapping up
In reaction to strong earnings/guidance: ITCI +47.5%, ELMD +6.1%, HPQ +1.3%, UNFI +0.7%, ASNA +0.7%
M&A news: ADEP +62.4% (to be acquired by OMRON for $13 per share), JST +10.1% (receives a 'going private' offer for $4.50/share from group including Chairman and CEO), STRZA +7.9% (Bloomberg reporting that co is in talks to be acquired by AMC Networks), SBMRY +2% (SABMiller plc confirms that Anheuser-Busch InBev SA/NV (BUD) has informed that it intends to make a proposal to acquire SABMiller)
Select spirit related names showing strength after BUD/SBMRY news: TAP +14.1%, ABEV +4.1%, DEO +2.7%
Other news: XNCR +25.4% (Xencor and Amgen (AMGN) announce a strategic collaboration in cancer immunotherapy; Xencor to receive a $45 mln upfront payment and up to $1.7 bln in milestone payments), SAEX +8.5% (announced three new project awards for onshore logistical support and seismic data acquisition services in North and South America, collectively valued at ~$90 mln), IMNP +8.1% (announced its CEO Dr. Daniel Teper has established a stock trading plan with respect to the purchases of up to an aggregate of $250k of shares of common stock), BUD +5.8% (Anheuser-Busch InBev confirms that it has made an approach to SABMiller's (SBMRY) Board regarding a combination of the two companies), GERN +4.2% (announces the dosing of the first patient in a Phase 2 clinical trial to evaluate imetelstat in patients with myelofibrosis), MO +4.1% (owns ~27% of SABMiller), FIT +4% (Bloomberg discusses that Target (TGT) plans to offer Fitbit Watches to 335K employees), CGEN +3.6% (reports new target validation results for CGEN-15052), NVAX +3.2% (announces that its RSV F Vaccine was shown to be highly immunogenic in a guinea pig model of maternal immunization), SUNE +0.8% (announces that a California court has granted the company's motion to dismiss charges filed by SunPower Corp), BABA +0.7% (affiliate sign MOU with USPS to increase cross-border logistics services)
Analyst comments: ORAN +2.1% (upgraded to Buy at Deutsche Bank), YNDX +1.7% (upgraded to Neutral from Sell at Goldman), ORCL +1.2% (upgraded to Buy from Neutral at Sun Trust Rbsn Humphrey), SNY +0.9% (upgraded to Buy at Safra Sarasin), GE +0.8% (added to U.S. and Global Focus Lists at Credit Suisse), ZION +0.7% (upgraded to Buy from Neutral at Goldman), JPM +0.6% (upgraded to Outperform from Market Perform at BMO Capital)
In reaction to strong earnings/guidance: ITCI +47.5%, ELMD +6.1%, HPQ +1.3%, UNFI +0.7%, ASNA +0.7%
M&A news: ADEP +62.4% (to be acquired by OMRON for $13 per share), JST +10.1% (receives a 'going private' offer for $4.50/share from group including Chairman and CEO), STRZA +7.9% (Bloomberg reporting that co is in talks to be acquired by AMC Networks), SBMRY +2% (SABMiller plc confirms that Anheuser-Busch InBev SA/NV (BUD) has informed that it intends to make a proposal to acquire SABMiller)
Select spirit related names showing strength after BUD/SBMRY news: TAP +14.1%, ABEV +4.1%, DEO +2.7%
Other news: XNCR +25.4% (Xencor and Amgen (AMGN) announce a strategic collaboration in cancer immunotherapy; Xencor to receive a $45 mln upfront payment and up to $1.7 bln in milestone payments), SAEX +8.5% (announced three new project awards for onshore logistical support and seismic data acquisition services in North and South America, collectively valued at ~$90 mln), IMNP +8.1% (announced its CEO Dr. Daniel Teper has established a stock trading plan with respect to the purchases of up to an aggregate of $250k of shares of common stock), BUD +5.8% (Anheuser-Busch InBev confirms that it has made an approach to SABMiller's (SBMRY) Board regarding a combination of the two companies), GERN +4.2% (announces the dosing of the first patient in a Phase 2 clinical trial to evaluate imetelstat in patients with myelofibrosis), MO +4.1% (owns ~27% of SABMiller), FIT +4% (Bloomberg discusses that Target (TGT) plans to offer Fitbit Watches to 335K employees), CGEN +3.6% (reports new target validation results for CGEN-15052), NVAX +3.2% (announces that its RSV F Vaccine was shown to be highly immunogenic in a guinea pig model of maternal immunization), SUNE +0.8% (announces that a California court has granted the company's motion to dismiss charges filed by SunPower Corp), BABA +0.7% (affiliate sign MOU with USPS to increase cross-border logistics services)
Analyst comments: ORAN +2.1% (upgraded to Buy at Deutsche Bank), YNDX +1.7% (upgraded to Neutral from Sell at Goldman), ORCL +1.2% (upgraded to Buy from Neutral at Sun Trust Rbsn Humphrey), SNY +0.9% (upgraded to Buy at Safra Sarasin), GE +0.8% (added to U.S. and Global Focus Lists at Credit Suisse), ZION +0.7% (upgraded to Buy from Neutral at Goldman), JPM +0.6% (upgraded to Outperform from Market Perform at BMO Capital)